The US Food and Drug Administration (FDA) has accepted to review AstraZeneca's new drug application (NDA) for Epanova, an investigational compound for the treatment for patients with severe hypertriglyceridaemia. Omthera Pharmaceuticals, ...
PTS, a manufacturer of the CardioChek family of point-of-care diagnostic products, has unveiled its new analyzer called CardioChek Plus, designed to check lipids and glucose in blood simultaneously. The CardioChek Plus provides rapid ...
Tags: Blood Simultaneously, Medicine
A group of researchers and scientists in the US has found that breathing vehicle tailpipe emissions can turn ‘good’ cholesterol into ‘bad’ cholesterol, contributing to clogged and hardened arteries and other related ...
Tags: Vehicle, Transportation
Mylan Pharmaceuticals, the subsidiary of Mylan, has introduced Fenofibrate tablets, 48 mg and 145 mg. The company has received the final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application ...
Tags: Mylan, Generic Version
HDL Design House has appointment Airics to act as representative for its digital and analogue IP chip design and verification businerss in the Nordic region. Sweden-based Airics will be in charge of sales and promotion of HDL DH products ...
Tags: Electrical, Electron
Tanner EDA has released version 16 of its HiPer Silicon full-flow design suite, offering a complete analogue and mixed-signal design flow from digital (HDL) and analogue (Spice, Verilog-A) electrical design and simulation, through synthesis ...
S&V Megasound won a highly competitive bid, beating a large number of companies (mainly based in Cyprus). They were selected to develop the AV infrastructure for this new leisure project Cyprus' capital city - chosen for their ability to ...
Tags: RCF, S&V Megasound, Nicosia
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. Fenofibrate Capsules, which are generic equivalent to Lupin Atlantis Holdings' Antara Capsules, are ...
Tags: Mylan Pharmaceuticals, Fenofibrate Capsules, pharmaceutical company
Aegerion Pharmaceuticals' Juxtapid (lomitapide) capsules has received US FDA approval to be used as an adjunct to a low-fat diet and other lipid-lowering treatments. Juxtapid, which is a supplement to fat reduction treatments also ...
Tags: Juxtapid, US, FDA, capsules, treatments
Polymer Technology Systems has entered into a multiyear agreement to supply its CardioChek PA test system to Life Line Screening. The CardioChek test system, which provides the results in less than two minutes, provides on-site lipid ...
Tags: Polymer, CardioChek test system, agreement, Life Line Screening
Iverson Genetic Diagnostics has signed an agreement with Johns Hopkins University School of Medicine to license a molecular diagnostics test which determines cardiovascular risk in men and women and infertility risk in women. Under the ...
Tags: Iverson, agreement, molecular diagnostics test, heart disease
Polymer Technology Systems (PTS) has signed a multiyear agreement to supply the CardioChek test system to Life Line Screening, a provider of community-based preventive health screenings. The test system supports on-site lipid panel ...
Iverson Genetic Diagnostics has entered into a licensing agreement with Johns Hopkins University School of Medicine for a molecular diagnostics test, designed to help physicians to assess cardiovascular risk in men and women, and ...
Tags: Iverson Genetic Diagnostics, SR-BI, molecular diagnostics test
Merck has issued an update on the development programs for vorapaxar, extended release niacin/laropirprant(MK524A,Tredaptive) and anacetrapib in association with the European Society of Cardiology (ESC) meeting in Munich, Bavaria. ...
Tags: Merck, vorapaxar, HPS2-THRIVE
Capstone Therapeutics and LipimetiX have formed LipimetiX Development , a joint venture (JV), to develop drugs that are used to treat indications of lowering blood cholesterol levels. The JV will develop a family of Apo E mimetic peptides ...
Tags: Apolipoprotein E, lipoprotein metabolism, Capstone Therapeutics